Naringin Regulates the Growth and Apoptosis of Ovarian Cancer Cells via the TGF-β Signaling Pathway: A Prospective Laboratory Based Study
Background: Traditional Chinese medicine (TCM) exhibits anti-tumor capabilities. This study explored the anti-tumor activity of Naringin in ovarian cancer and the signaling mechanism. Methods: The current investigation comprised the administration of various concentrations of Naringin, paclitaxel, a...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Book |
| Published: |
IMR Press,
2024-05-01T00:00:00Z.
|
| Subjects: | |
| Online Access: | Connect to this object online. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Summary: | Background: Traditional Chinese medicine (TCM) exhibits anti-tumor capabilities. This study explored the anti-tumor activity of Naringin in ovarian cancer and the signaling mechanism. Methods: The current investigation comprised the administration of various concentrations of Naringin, paclitaxel, and cisplatin to SKOV3 cells. Following the therapy, the protein expression levels for (TGF-β) and its downstream (Snail1)/(SMAD2) were measured in SKOV3 cells. Finally, small interfering RNA (siRNA) targeting TGF-β was synthesized, and the recombinant plasmid vector overexpressing TGF-β was constructed to detect the mRNA and protein expression of Snail1/SMAD2. The results were verified in animal models. Results: In this study, the expression of TGF-β varied significantly with varying Naringin concentrations. The expression of the downstream Snail1/SMAD2 was also affected. With increasing Naringin concentration, the expression of Snail1/SMAD2 decreased gradually in cells. Moreover, overexpressing TGF-β increased the expression of Snail1/SMAD2 and vice versa. In addition, Naringin further decreased the expression of Snail1/SMAD2 produced by transforming growth factor-β (TGF-β). Consistent outcomes were achieved when TGF-β agonists and inhibitors were employed alongside the inclusion of Naringin in animal models. Conclusions: The results of the present study demonstrated that Naringin suppressed the proliferation of ovarian cancer cells in a manner that depended on the dosage and also triggered programmed cell death (apoptosis) in ovarian cancer cells by activating the TGF-β mediated signaling pathway. |
|---|---|
| Item Description: | 0390-6663 10.31083/j.ceog5105111 |